Non-Clinical Literature
Macrophage phenotypes correspond with remodeling outcomes of various acellular dermal matrices
Macrophage phenotypes correspond with remodeling outcomes of various acellular dermal matrices
Beyond peer-reviewed publications, there are a number of case studies supporting the use of Dermacell AWM for treating hard-to-heal wounds. From diabetic foot ulcers, to trauma, and burn reconstruction, Dermacell AWM is effective for complete resolution with one application.
The Matracell process — utilized in dermal allografts — yields a strong, acellular scaffold that facilitates cell proliferation, cell migration and vascularization. Only tissue processed with Matracell technology meets the threshold of being truly decellularized, minimizing the possibility of an immune response.
Dermacell AWM is a technologically advanced human acellular dermal matrix that is decellularized using Matracell®, a proprietary, patented, and validated processing technology. Matracell removes a minimum of 97% of donor DNA1, allowing for rapid cellular infiltration and re-vascularization. Dermacell AWM is terminally sterilized, ready to use without refrigeration or re-hydration.
The Ross Procedure: Advanced Surgical Techniques for a Successful Outcome
Abla A, El Kadi H, Bost J, Maroon J, and Wert M. Allograft Composite Cortical and Cancellous Bone Graft for Anterior Cerival Fusion.Contemporary Neurosurgery: A Biweekly Publication for Clinical Neurosurgical Continuing Medical Education. 2005;27(8):1-6.
There is a growing body of clinical evidence supporting ViviGen and ViviGen Formable cellular bone matrix, including recent data that shows effective multi-level fusion even in challenging cases.
WEDNESDAY, SEPTEMBER 25 10AM & 3PM
THURSDAY, SEPTEMBER 26 10AM & 3PM
AT OUR HANDLING STATION IN NASS BOOTH 4024
Many commercial DBMs utilize an inert carrier to improve handling, and the proportion of demineralized bone content in the graft varies widely by manufacturer.